Reuters file photo
London, July 23
The European Medicines Agency has recommended approving Moderna's COVID-19 vaccine for children aged 12 to 17, the first time the shot has been authorised for people under 18.
In a decision on Friday, the EU drug regulator said research in more than 3,700 children aged 12 to 17 showed that the Moderna vaccine — already given the OK for adults across Europe — produced a comparable antibody response.
Until now, the vaccine made by Pfizer and its German partner BioNTech has been the only option for children in North America and Europe.
The US Food and Drug Administration is currently considering whether to extend the use of the Moderna vaccine for children under 18.
With global vaccine supplies still tight, much of the world still is struggling to immunize adults. US and European regulators do caution that both the Moderna and Pfizer vaccines appear linked to an extremely rare reaction in teens and young adults — chest pain and heart inflammation. — AP
Join Whatsapp Channel of The Tribune for latest updates.
Most Read In 24 Hours
Don't Miss
View All
Top News
Congress nominee's ‘Constitution forced on Goa’ remarks invite PM’s ire; BJP files complaint
A defiant Fernandes says he is ready for a debate on his con...
'My mother's mangalsutra was sacrificed for this country'; Priyanka Gandhi's blistering attack on PM
Priyanka was referring to Modi's allegations that the Congre...
Excise policy case: Arvind Kejriwal, Kavitha to remain in jail as Delhi court extends their judicial custody till May 7
They were produced before the court through video conference...
Misleading advertisements: Supreme Court turns heat on IMA; poses questions on alleged unethical conduct of its members
A Bench led by Justice Hima Kohli expands scope of hearing a...
Why is Prime Minister Narendra Modi building on ‘M’ factor, is low voter turnout in Phase 1 the reason?
Attacking the Congress using the ‘M’—manifesto, ‘mangalsutra...
